News

Biocair

Innovative technologies...

Publication date : 2019-10-29

The project BioCAIRBIOmarkers of T-Cell Activity in tumors and Immunotherapy Response – is financed by European funds (FEDER).

Diaclone brings its competences in antibody development and engineering to this project, with the support of the mAbexperts team.

More information here or visit our collaborations page: https://www.diaclone.com/about/collaborations

Other news

  • POLEPHARMA
    POLEPHARMA Biotesting Congress
    Publication date : 2020-01-17
    mAbexperts is sponsor of the POLEPHARMA Biotesting Congress - 1st edition, held in Évreux - Normandie (France) on the 4th & 5th February 2020. Read more
  • B4B Strasbourg
    Bioproduction vol.9 B4B-Connection Meeting, Strasbourg, 5-6 February 2020
    Publication date : 2020-01-14
    The mAbexperts group will be attending the Bioproduction vol.9 B4B-Connection Meeting in Strasbourg (France) on the 5th and 6th February 2020 Read more
  • Diaclone's Toolbox
    Use Diaclone’s Toolbox to monitor your CAR-T cell responses
    Publication date : 2019-12-16
    In vitro studies with Diaclone’s Toolbox to monitor the risks linked to immunotherapy.... Read more
  • Toolbox
    Diaclone's Toolbox for your Car-T Development
    Publication date : 2019-11-12
    Our Monoclonal Antibodies and ELISpot range are valuable tools for your CAR-T research. Read more
  • CAR-T development
    CAR-T development
    Publication date : 2019-10-01
    How can Diaclone support your CAR-T development? Read more
  • Diaclone est partenaire d’un projet européen d’envergure associant une douzaine de partenaires de la région de Besançon.
    MiMédi Project
    Publication date : 2019-08-29
    Diaclone is a partner in a major European project involving a dozen partners from the Besançon region. Read more

Product search